Masimo Corp Files Proxy Soliciting Material
Ticker: MASI · Form: DEFA14A · Filed: May 20, 2024 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | DEFA14A |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $200, $300 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, soliciting-material, corporate-governance
Related Tickers: MASI
TL;DR
MASI proxy filing out - looks like they're talking to shareholders.
AI Summary
Masimo Corporation filed a DEFA14A, indicating it is providing soliciting material under Rule 240.14a-12. This filing is not a preliminary proxy statement or definitive additional materials, but rather material used to solicit proxies. The company is based in Irvine, CA, and operates in the electromedical apparatus industry.
Why It Matters
This filing indicates Masimo Corporation is actively engaging shareholders, likely in preparation for a shareholder meeting or vote, which could impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — This is a standard proxy filing and does not inherently present new risks to the company or its investors.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- 3845 (industry_code) — Standard Industrial Classification
- DE (state) — State of Incorporation
- CA (state) — Business Address State
- 949-297-7000 (phone_number) — Business Phone
FAQ
What is the purpose of this DEFA14A filing?
This DEFA14A filing is for soliciting material pursuant to Section 240.14a-12 of the Securities Exchange Act of 1934, indicating Masimo Corporation is seeking shareholder input or votes.
Is this a preliminary or definitive proxy statement?
This filing is classified as 'Soliciting Material Pursuant to §240.14a-12' and is not marked as a Preliminary Proxy Statement or Definitive Proxy Statement.
Where is Masimo Corporation headquartered?
Masimo Corporation's business and mailing address is located at 52 Discovery, Irvine, CA 92618.
What is Masimo Corporation's Standard Industrial Classification code?
Masimo Corporation's Standard Industrial Classification code is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
What is the filing fee status for this document?
The filing fee status indicates 'No fee required'.
Filing Stats: 1,989 words · 8 min read · ~7 pages · Grade level 10.9 · Accepted 2024-05-17 20:45:40
Key Financial Figures
- $200 — ulse oximetry drop is going to be about $200, with the camera, you’re talking
- $300 — the camera, you’re talking about $300. It should change everything. There has
Filing Documents
- ea0206504-defa14a_masimo.htm (DEFA14A) — 25KB
- image_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-044874.txt ( ) — 30KB
Forward-Looking Statements
Forward-Looking Statements This communication includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo Corporation (“Masimo” or the “Company”), a potential spin-off involving Masimo, the evaluation of a potential separation of Masimo’s Consumer Business, the potential advantages and disadvantages of any such separation, the launch of a new generation Root product and the expected timing of such launch and product development and manufacturing strategies with respect to Masimo’s Consumer Business. These forward-looking statements are based on current expectations about future events affecting Masimo and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding a potential separation of Masimo’s Consumer Business, (ii) uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (iii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iv) factors discussed in the “Risk Factors” section of Masimo’s most recent reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at www.sec.gov . Although Masimo believe